Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Acute Myelogenous Leukemia
>>
Sanofi
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
3
6
9
12
15
18
21
24
27
30
plerixafor
/ Generic mfg.
Caprelsa
(vandetanib) / Sanofi
pimasertib
(AS703026) / Day One Biopharma